Leiden, Netherlands

Indigo King

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Vaccines & Prevention B.v.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Indigo King. Retrieved from https://idiyas.com/inventor/indigo-king-vxg6jxmd

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Indigo King

Introduction

Indigo King is a remarkable inventor based in Leiden, Netherlands. She has made significant contributions to the field of vaccine development, particularly in the area of influenza. Her work is characterized by a commitment to advancing public health through innovative solutions.

Latest Patents

Indigo King holds a patent for "Recombinant Influenza Antigens." This patent represents her dedication to creating effective vaccines that can combat influenza viruses. With 1 patent to her name, she is making strides in the scientific community.

Career Highlights

Indigo King is currently employed at Janssen Vaccines & Prevention B.V. This company is known for its cutting-edge research and development in the field of vaccines. Her role at Janssen allows her to collaborate with other experts and contribute to groundbreaking projects.

Collaborations

Due to space constraints, the details of her collaborations will not be included.

Conclusion

Indigo King's work exemplifies the spirit of innovation in the field of vaccine development. Her contributions are vital in the ongoing fight against infectious diseases, and her achievements inspire future generations of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…